ARTICLE | Finance

1Q Stock Wrap-Up: Small but mighty

Microcaps gain double-digits in 1Q14 as all biotech segments finish in black

April 7, 2014 7:00 AM UTC

Despite a correction at the end of March, all biotech market cap segments finished the first quarter in positive territory. Microcaps set the pace with a 10% gain, while large caps added 7% and were the second best performing group (see "Results by Market Cap").

The correction saw the BioCentury 100 index fall 12% in the two-week period ending March 28. During that stretch, the NASDAQ fell 2%, the Dow Jones gained 2% and the S&P rose 1%...